Novel benzo-bis(1,2,5-thiadiazole) fluorophores for in vivo NIR-II imaging of cancer-Reference-Cited by-同舟云学术

Novel benzo-bis(1,2,5-thiadiazole) fluorophores for in vivo NIR-II imaging of cancer

Published:2016 Issue:9 Volume:7 Page:6203-6207
ISSN:2041-6520
Container-title:Chemical Science
language:en
Short-container-title:Chem. Sci.

Author:

Sun Yao¹²³⁴⁵,Qu Chunrong¹²³⁴⁵,Chen Hao⁶⁷⁸⁹¹⁰,He Maomao¹²³⁴⁵,Tang Chu⁶⁷⁸⁹¹⁰,Shou Kangquan⁶⁷⁸⁹¹⁰,Hong Suhyun⁶⁷⁸⁹¹⁰,Yang Meng¹¹¹²¹³¹⁴⁵,Jiang Yuxin¹¹¹²¹³¹⁴⁵,Ding Bingbing¹²³⁴⁵,Xiao Yuling¹²³⁴⁵,Xing Lei⁶⁷⁸⁹¹⁰,Hong Xuechuan¹²³⁴⁵,Cheng Zhen⁶⁷⁸⁹¹⁰

Affiliation:

1. State Key Laboratory of Virology

2. Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (MOE) and Hubei Provincial Key Laboratory of Developmentally Originated Disease

3. Wuhan University School of Pharmaceutical Sciences

4. Wuhan 430071

5. China

6. Molecular Imaging Program at Stanford (MIPS)

7. Bio-X Program, and Department of Radiology

8. Canary Center at Stanford for Cancer Early Detection

9. Stanford University

10. California 94305-5344

11. Chinese Academy of Medical Science

12. Peking Union Medical College Hospital

13. Department of Ultrasound

14. Beijing

Abstract

Optical imaging of diseases represents a highly dynamic and multidisciplinary research area, and second near-infrared window (NIR-II, 1000–1700 nm) imaging is at the forefront of the research on optical imaging techniques.

Funder

Office of Science

National Institutes of Health

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/SC/C6SC01561A

Reference28 articles.

1. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes